These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 14584417

  • 21. Dispersions of repolarization and ventricular arrhythmogenesis: lessons from animal models.
    Killeen MJ, Sabir IN, Grace AA, Huang CL.
    Prog Biophys Mol Biol; 2008; 98(2-3):219-29. PubMed ID: 19027779
    [Abstract] [Full Text] [Related]

  • 22. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias.
    Furukawa T, Kurokawa J.
    Pharmacol Ther; 2007 Jul; 115(1):106-15. PubMed ID: 17583354
    [Abstract] [Full Text] [Related]

  • 23. Current perspectives on congenital long QT syndrome.
    Delaney J, Mittal S, Sherrid MV.
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():3-11. PubMed ID: 20089481
    [Abstract] [Full Text] [Related]

  • 24. Effects of antiarrhythmic drugs on QT interval dispersion--relationship to antiarrhythmic action and proarrhythmia.
    Gillis AM.
    Prog Cardiovasc Dis; 2000 Dec; 42(5):385-96. PubMed ID: 10768315
    [Abstract] [Full Text] [Related]

  • 25. The long QT syndrome: therapeutic implications of a genetic diagnosis.
    Shimizu W.
    Cardiovasc Res; 2005 Aug 15; 67(3):347-56. PubMed ID: 15979599
    [Abstract] [Full Text] [Related]

  • 26. Role of potassium currents in cardiac arrhythmias.
    Ravens U, Cerbai E.
    Europace; 2008 Oct 15; 10(10):1133-7. PubMed ID: 18653669
    [Abstract] [Full Text] [Related]

  • 27. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin JP.
    Fundam Clin Pharmacol; 2004 Apr 15; 18(2):139-51. PubMed ID: 15066127
    [Abstract] [Full Text] [Related]

  • 28. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P, Pott C, Eckardt L, Breithardt G.
    Dtsch Med Wochenschr; 2008 Dec 15; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [Abstract] [Full Text] [Related]

  • 29. [Electrocardiogram in channel disorders].
    González-Hermosillo JA.
    Arch Cardiol Mex; 2004 Dec 15; 74 Suppl 1():S79-83. PubMed ID: 15216752
    [Abstract] [Full Text] [Related]

  • 30. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY, Yang SJ.
    Yao Xue Xue Bao; 2007 Jul 15; 42(7):687-91. PubMed ID: 17882949
    [Abstract] [Full Text] [Related]

  • 31. Significance of QT dispersion in the long QT syndrome.
    Napolitano C, Priori SG, Schwartz PJ.
    Prog Cardiovasc Dis; 2000 Jul 15; 42(5):345-50. PubMed ID: 10768312
    [Abstract] [Full Text] [Related]

  • 32. Short QT syndrome. Update on a recent entity.
    Maury P, Extramiana F, Sbragia P, Giustetto C, Schimpf R, Duparc A, Wolpert C, Denjoy I, Delay M, Borggrefe M, Gaita F.
    Arch Cardiovasc Dis; 2008 Jul 15; 101(11-12):779-86. PubMed ID: 19059573
    [Abstract] [Full Text] [Related]

  • 33. Vulnerable substrate and multiple ion channel disorder in a diseased heart will be new targets for antiarrhythmic therapy.
    Dai DZ.
    Acta Pharmacol Sin; 2000 Apr 15; 21(4):289-95. PubMed ID: 11324452
    [Abstract] [Full Text] [Related]

  • 34. Antipsychotic-induced sudden cardiac death: examination of an atypical reaction.
    Killeen MJ.
    Expert Opin Drug Saf; 2009 May 15; 8(3):249-52. PubMed ID: 19505259
    [Abstract] [Full Text] [Related]

  • 35. Clinical and molecular genetics of the short QT syndrome.
    Schimpf R, Borggrefe M, Wolpert C.
    Curr Opin Cardiol; 2008 May 15; 23(3):192-8. PubMed ID: 18382206
    [Abstract] [Full Text] [Related]

  • 36. Pharmacology of cardiac potassium channels.
    Tamargo J, Caballero R, Gómez R, Valenzuela C, Delpón E.
    Cardiovasc Res; 2004 Apr 01; 62(1):9-33. PubMed ID: 15023549
    [Abstract] [Full Text] [Related]

  • 37. Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome.
    Frank-Hansen R, Larsen LA, Andersen P, Jespersgaard C, Christiansen M.
    Clin Chim Acta; 2005 Jan 01; 351(1-2):95-100. PubMed ID: 15563876
    [Abstract] [Full Text] [Related]

  • 38. [New perspectives in long QT syndrome].
    Medeiros-Domingo A, Iturralde-Torres P, Canizales-Quinteros S, Hernández-Cruz A, Tusié-Luna MT.
    Rev Invest Clin; 2007 Jan 01; 59(1):57-72. PubMed ID: 17569301
    [Abstract] [Full Text] [Related]

  • 39. Genomics and cardiac arrhythmias.
    Roberts R.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):9-21. PubMed ID: 16386658
    [Abstract] [Full Text] [Related]

  • 40. Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.
    Tadros R, Cadrin-Tourigny J, Abadir S, Rivard L, Nattel S, Talajic M, Khairy P.
    Expert Rev Cardiovasc Ther; 2015 Jan 03; 13(7):769-82. PubMed ID: 25994014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.